Literature DB >> 33707841

Inherited Bleeding Disorders in Pediatric Patients; experience of the national referral center in Iraq.

Abbas Hashim Abdulsalam1, Nidhal Karim Al-Rahal2, Yusra Ghiath2.   

Abstract

BACKGROUND: Inherited bleeding disorders can lead to lifelong bleeding; they are mainly caused by quantitative or qualitative defect of coagulation factors, von Willebrand factor (VWF) or platelets. No published data are available about the different types of inherited bleeding disorders in Iraq.
OBJECTIVES: To describe types, severity and presentation of inherited bleeding disorders in pediatric patients in the major referral center in Iraq. PATIENTS AND METHODS: This is a cohort prospective descriptive study conducted at the National Center of Hematology, a referral center for bleeding disorders in Baghdad-Iraq, from January 2015 to December 2019. One hundred ninety-one patients, aged 1 day to 14 years, with suspected inherited bleeding disorder are included in this study. Each patient was interviewed, accompanied by a chaperone, mostly parent(s), with revision of personal and familial bleeding history, conducting a brief medical examination, and withdrawing blood for complete blood count, peripheral blood film, bleeding time, PT and APTT. Further investigations including mixing studies, lupus anticoagulant, clotting factor activity, VWF:antigen (VWF:Ag), VWF: Ristocetin cofactor (VWF:RiCof) and platelet function tests using light transmission aggregometry were performed only if indicated.
RESULTS: The mean ± 1SD of age of patients is 5.3 ± 3 years, with a male:female ratio of 1.3:1. Family history of a similar bleeding disorder is recorded in 44.9% patients (P < 0.05). Consanguineous marriage was observed in 70.8% of the families (P < 0.001). The most prevalent inherited bleeding disorder is von Willebrand disease (VWD) (43.9%), of which type 3 is the most common (86.9%). Thrombasthenia is the second most prevalent (39.8%) inherited bleeding disorder; of these, the majority have Glanzmann's thrombasthenia (82.9%). Hemophilia A is found in 9.4% of patients.
CONCLUSION: Type 3 VWD, Glanzmann's thrombasthenia and hemophilia A are the most common inherited bleeding disorders in the central part of Iraq, collectively they constitute  >86% of patients. Consanguineous marriage should be discouraged in our society to decrease hereditary bleeding disorders. Also, there is a need to increase awareness and knowledge of bleeding disorders to improve early identification, mitigate the risk of further bleeding and prevent complications. © Indian Society of Hematology and Blood Transfusion 2020.

Entities:  

Keywords:  Glanzmann thrombasthenia; Hemophilia A; Inherited bleeding disorders; Severity of bleeding; Von willebrand disease

Year:  2020        PMID: 33707841      PMCID: PMC7900310          DOI: 10.1007/s12288-020-01306-8

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  11 in total

1.  Relatively high frequency of VWD types 3 and 2 in a cohort of Indian patients: the role of multimeric analysis.

Authors:  P K Gupta; R P H Ahmed; S Sazawal; V P Choudhry; R Saxena
Journal:  J Thromb Haemost       Date:  2005-06       Impact factor: 5.824

Review 2.  Genetic diagnosis of haemophilia and other inherited bleeding disorders.

Authors:  F Peyvandi; G Jayandharan; M Chandy; A Srivastava; S M Nakaya; M J Johnson; A R Thompson; A Goodeve; I Garagiola; S Lavoretano; M Menegatti; R Palla; M Spreafico; L Tagliabue; R Asselta; S Duga; P M Mannucci
Journal:  Haemophilia       Date:  2006-07       Impact factor: 4.287

3.  7th revision of the Declaration of Helsinki: good news for the transparency of clinical trials.

Authors:  Karmela Krleza-Jerić; Trudo Lemmens
Journal:  Croat Med J       Date:  2009-04       Impact factor: 1.351

4.  Evaluation of Pediatric Bleeding Questionnaire in Turkish Children With Von Willebrand Disease and Platelet Function Disorders.

Authors:  Burcu Belen; Ulker Kocak; Melek Isik; Ebru Yilmaz Keskin; Nergiz Oner; Ertan Sal; Zuhre Kaya; Idil Yenicesu; Turkiz Gursel
Journal:  Clin Appl Thromb Hemost       Date:  2014-02-20       Impact factor: 2.389

5.  Hereditary bleeding disorders in Riyadh, Saudi Arabia.

Authors:  I M Al-Fawaz; A M Gader; H M Bahakim; F Al-Mohareb; A K Al-Momen; M S Harakati
Journal:  Ann Saudi Med       Date:  1996-05       Impact factor: 1.526

Review 6.  Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.

Authors:  J E Sadler; U Budde; J C J Eikenboom; E J Favaloro; F G H Hill; L Holmberg; J Ingerslev; C A Lee; D Lillicrap; P M Mannucci; C Mazurier; D Meyer; W L Nichols; M Nishino; I R Peake; F Rodeghiero; R Schneppenheim; Z M Ruggeri; A Srivastava; R R Montgomery; A B Federici
Journal:  J Thromb Haemost       Date:  2006-08-02       Impact factor: 5.824

7.  Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.

Authors:  F Peyvandi; R Palla; M Menegatti; S M Siboni; S Halimeh; B Faeser; H Pergantou; H Platokouki; P Giangrande; K Peerlinck; T Celkan; N Ozdemir; C Bidlingmaier; J Ingerslev; M Giansily-Blaizot; J F Schved; R Gilmore; A Gadisseur; M Benedik-Dolničar; L Kitanovski; D Mikovic; K M Musallam; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

8.  Inherited platelet function disorders versus other inherited bleeding disorders: an Indian overview.

Authors:  Firdos Ahmad; Meganathan Kannan; Ravi Ranjan; Jyoti Bajaj; Ved P Choudhary; Renu Saxena
Journal:  Thromb Res       Date:  2007-09-11       Impact factor: 3.944

9.  Presentation and diagnosis of patients with type 3 von Willebrand disease in resources-limited laboratory.

Authors:  Abbas Hashim Abdulsalam; Yusra Ghiath; Nidhal Alrahal
Journal:  Hematol Oncol Stem Cell Ther       Date:  2018-07-03

Review 10.  The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.

Authors:  Mike A Laffan; Will Lester; James S O'Donnell; Andrew Will; Robert Campbell Tait; Anne Goodeve; Carolyn M Millar; David M Keeling
Journal:  Br J Haematol       Date:  2014-08-12       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.